Research
Virtual screening of Withania somnifera phytochemicals identifies scopoletin and linoleic acid as predicted dual-target AChE/BACE1 candidates for alzheimer’s disease
Nature ·
The Brief
- A virtual screening study examined Withania somnifera phytochemicals against AChE and BACE1, two enzyme targets in Alzheimer's disease.
- The study predicts scopoletin and linoleic acid as dual-target candidates; these are computational predictions, not lab or clinical results.
Why it matters
The work is an early computational screen that narrows down candidate compounds for Alzheimer's drug research. Predicted binding does not establish efficacy or safety, so the findings need experimental validation before they mean anything for patients.
Who’s affected
- Alzheimer's drug discovery researchers
- #alzheimers
- #virtual-screening
- #drug-discovery
- #phytochemicals
- #withania-somnifera